Physician profile
Mallory Kuchem
NPI 1750633103
$2,675.42
in general payments reported to CMS, 2019-2025
16 companies · $609 in 2025
The $609 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $262 · 2021: $57.95 · 2022: $457 · 2023: $320 · 2024: $360 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Entertainment: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.56 |
| Entertainment | $105.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $563.59 | 2019-2025 | Precision7, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $370.44 | 2022-2025 | Infuse, Alden Scleral Zenlens, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $222.44 | 2019-2021 | |
| Maculogix, INC. | $215.87 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $193.51 | 2020-2025 | Cequa |
| Glaukos Corporation | $174.66 | 2025 | Photrexa Viscous and Photrexa |
| Biotissue Holdings INC. | $167.74 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $157.98 | 2024-2025 | Xdemvy |
| Optos, INC. | $148.40 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $122.16 | 2022-2024 | |
| Coopervision INC. | $116.31 | 2019-2025 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $90.90 | 2022-2025 | |
| Oyster Point Pharma, INC. | $50.77 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $36.85 | 2022 | |
| Spark Therapeutics, INC. | $27.83 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Kuchem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.